Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.736 USD | +2.12% | -5.13% | -42.32% |
May. 10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |